In his legal analysis of the Physician Payment Sunshine Act, Alexandros Stamatoglou writes:
"AstraZeneca compensated Dr. Olson and the University of Minnesota psychiatry department for each new recruit brought into the study to the tune of over $15,000 per recruit. Dr. Olson's financial ties with AstraZeneca ran deeper; he was paid $240,045
by the company between 2002 and 2008 for speaking engagements, consulting, and research grants. Regardless of whether Dr. Olson's medical judgment was actually impaired with respect to Dan Markingson's medical care, his financial stake in the CAFE study raises questions over physicians' commitment to patients in the face of outside financial interests."
The full article appears in The John Marshall Law Review.